Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813735 · ClinicalTrials.gov registry record · Phase 4
Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
A Phase 4 study of Insomnia, sponsored by Lehigh Center for Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00813735: Completed Phase 4 study of Insomnia, sponsored by Lehigh Center for Clinical Research.
NCT00813735 is a Phase 4 study of Insomnia that has completed, run by Lehigh Center for Clinical Research. The registered enrollment target is 60 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00813735, a Phase 4 study of Insomnia, has completed, sponsored by Lehigh Center for Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Research has established the incidence of insomnia increases with age and the possible causes contributing to sleep problems in the elderly are still being explored and debated. Older adults use a disproportionately large share of sleep aids with non-prescription sleep aid use having increased over the past decade. This study is a double blind safety and effectiveness trial examining the response of eszopiclone co-administered with escitalopram for the treatment of insomnia symptoms in geriatric depressed adults with insomnia symptoms.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Escitalopram
- DRUG Eszopiclone
Study Locations (1)
Pennsylvania
- Lehigh Center for Clinical Research - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
What the finished NCT00813735 record still lists
NCT00813735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00813735 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00813735 about?
NCT00813735 is a clinical study titled "Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder". Research has established the incidence of insomnia increases with age and the possible causes contributing to sleep problems in the elderly are still being explored and debated. Older adults use a disproportionately large share of sleep aids with non-prescription sleep aid use having increased over ...
What is the current status of trial NCT00813735?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-09. Estimated completion is 2009-04.
What conditions does trial NCT00813735 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT00813735?
The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG), Eszopiclone (DRUG).
Who is sponsoring clinical trial NCT00813735?
This trial is sponsored by Lehigh Center for Clinical Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00813735 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00813735's enrollment target sits among peer trials
60 89th of 151 higher than 58 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
RECRUITING · Phase 4
-
Enhancing Hypnotic Medication Discontinuation in Primary Care
RECRUITING · Phase 4
-
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
RECRUITING · Phase 4
-
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
ACTIVE NOT RECRUITING · Phase 4
-
A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia